目次

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 52)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 LATERAL FLOW ASSAYS MARKET SEGMENTATION
1.3.2 REGIONS COVERED
FIGURE 2 REGIONAL SCOPE
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
1.5.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY (Page No. - 57)
2.1 RESEARCH APPROACH
FIGURE 3 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Primary sources
2.1.2.2 Key data from primary sources
2.1.2.3 Breakdown of primaries
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 5 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2022)
FIGURE 7 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAYS INDUSTRY (2022)
FIGURE 8 APPROACH 3: DEMAND-SIDE APPROACH, BASED ON MALARIA LATERAL FLOW TESTING MARKET SIZE (2022)
FIGURE 9 APPROACH 4: TOP-DOWN APPROACH
FIGURE 10 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023-2029): IMPACT ON MARKET GROWTH AND CAGR
FIGURE 11 CAGR PROJECTIONS
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 12 DATA TRIANGULATION METHODOLOGY
2.4 KEY INDUSTRY INSIGHTS
2.5 LIMITATIONS
2.5.1 METHODOLOGY-RELATED LIMITATIONS
2.6 RISK ASSESSMENT
2.7 STUDY ASSUMPTIONS
2.8 RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY (Page No. - 70)
FIGURE 13 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023 VS. 2029 (USD MILLION)
FIGURE 14 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023 VS. 2029 (USD MILLION)
FIGURE 15 LATERAL FLOW ASSAYS INDUSTRY, BY APPLICATION, 2023 VS. 2029 (USD MILLION)
FIGURE 16 MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023 VS. 2029 (USD MILLION)
FIGURE 17 MARKET, BY END USER, 2023 VS. 2029 (USD MILLION)
FIGURE 18 MARKET: GEOGRAPHICAL SNAPSHOT

4 PREMIUM INSIGHTS (Page No. - 74)
4.1 LATERAL FLOW ASSAYS MARKET OVERVIEW
FIGURE 19 HIGH PREVALENCE OF INFECTIOUS DISEASES TO DRIVE MARKET
4.2 REGIONAL MIX: MARKET
FIGURE 20 ASIA PACIFIC TO REGISTER HIGHEST CAGR OVER FORECAST PERIOD
4.3 ASIA PACIFIC: MARKET, BY APPLICATION AND COUNTRY (2022)
FIGURE 21 CLINICAL TESTING SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
4.4 MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
FIGURE 22 CHINA TO REGISTER HIGHEST GROWTH OVER FORECAST PERIOD
4.5 MARKET: DEVELOPED COUNTRIES VS. EMERGING ECONOMIES
FIGURE 23 EMERGING ECONOMIES TO OFFER HIGH GROWTH OPPORTUNITIES IN FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 77)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 24 LATERAL FLOW ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 High prevalence of infectious diseases
TABLE 2 PREVALENCE OF HIV WORLDWIDE (2017 VS. 2021)
5.2.1.2 Rising geriatric population
FIGURE 25 GERIATRIC POPULATION, BY REGION, 2020 VS. 2050 (MILLION)
FIGURE 26 GERIATRIC POPULATION, BY REGION, 2022 VS. 2030 VS. 2050 (% OF TOTAL POPULATION)
5.2.1.3 Growing use of home-based lateral flow assay devices
5.2.1.4 Growing demand for POC testing
5.2.2 RESTRAINTS
5.2.2.1 Inconsistent results of lateral flow assay tests
5.2.3 OPPORTUNITIES
5.2.3.1 Evolving applications of lateral flow assays
TABLE 3 LIST OF COMMERCIALLY AVAILABLE SALIVA LFA PRODUCTS
5.2.3.2 Rising demand for lateral flow assays in food & beverage industry
5.2.3.3 Emergence of Omicron COVID variant
TABLE 4 EPIDEMIOLOGICAL UPDATE ON OMICRON VARIANT
TABLE 5 EXAMPLES OF LATERAL FLOW ASSAY KITS AVAILABLE TO DETECT OMICRON
5.2.4 CHALLENGES
5.2.4.1 Limited reimbursements for lateral flow assay products
5.2.4.2 Difficulties in procuring quality raw materials to develop tests
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 27 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.4 PRICING ANALYSIS
5.4.1 AVERAGE SELLING PRICE TREND, BY APPLICATION
TABLE 6 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAYS (KITS & REAGENTS), BY COMPANY AND APPLICATION, 2021-2023
5.4.2 AVERAGE SELLING PRICE TREND, BY REGION
TABLE 7 AVERAGE SELLING PRICE OF LATERAL FLOW ANALYZERS, BY REGION, 2020 VS. 2022
5.5 ECOSYSTEM
TABLE 8 LATERAL FLOW ASSAYS INDUSTRY: ECOSYSTEM ANALYSIS (2022)
5.6 SUPPLY CHAIN ANALYSIS
5.6.1 PROMINENT COMPANIES
5.6.2 SMALL & MEDIUM-SIZED COMPANIES
5.6.3 END USERS
5.7 PATENT ANALYSIS
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS
FIGURE 28 GLOBAL PATENT PUBLICATION TRENDS IN MARKET, 2013-2023
5.7.2 TOP APPLICANTS (COMPANIES) OF LATERAL FLOW ASSAY PATENTS
FIGURE 29 TOP COMPANIES THAT APPLIED FOR LATERAL FLOW ASSAY PATENTS, 2016-2022
5.7.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN MARKET
FIGURE 30 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAY PATENTS, 2016-2022
5.8 VALUE CHAIN ANALYSIS
FIGURE 31 MARKET: VALUE CHAIN ANALYSIS (2022)
5.9 TECHNOLOGY ANALYSIS
5.9.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS
5.9.2 ADJACENT TECHNOLOGY: ELISA (ENZYME-LINKED IMMUNOSORBENT ASSAYS)
5.10 CASE STUDY ANALYSIS
5.10.1 CASE STUDY 1: QUIDEL LAUNCHES NEW TEST WITH BROADER DETECTION WINDOW
5.10.2 CASE STUDY 2: ABINGTON OFFERS HIGH-SENSITIVITY TESTS FOR GREATER QUALITY
5.10.3 CASE STUDY 3: SIEMENS OFFERS HIGH-SENSITIVITY TROPONIN I ASSAY TO RAPIDLY DETECT ACUTE MYOCARDIAL INFARCTION
5.11 REGULATORY ANALYSIS
5.11.1 REGULATORY LANDSCAPE
5.11.1.1 North America
5.11.1.2 Europe
5.11.1.3 Asia
5.11.1.3.1 India
5.11.1.3.2 China
5.11.1.3.3 Japan
5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.11.2.1 North America
TABLE 9 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.11.2.2 Europe
TABLE 10 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.11.2.3 Asia Pacific
TABLE 11 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.11.2.4 Latin America
TABLE 12 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.11.2.5 Rest of the world
TABLE 13 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.12 PORTER’S FIVE FORCES ANALYSIS
TABLE 14 MARKET: PORTER’S FIVE FORCES ANALYSIS
5.12.1 THREAT OF NEW ENTRANTS
5.12.2 THREAT OF SUBSTITUTES
5.12.3 BARGAINING POWER OF SUPPLIERS
5.12.4 BARGAINING POWER OF BUYERS
5.12.5 INTENSITY OF COMPETITIVE RIVALRY
5.13 ADJACENT MARKET ANALYSIS
FIGURE 32 LATERAL FLOW ASSAYS: OVERVIEW OF ADJACENT MARKETS
5.14 KEY CONFERENCES AND EVENTS, 2023-2024
TABLE 15 MARKET: DETAILED LIST OF CONFERENCES & EVENTS
5.15 TRADE ANALYSIS
5.15.1 IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS
TABLE 16 IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2018-2022 (USD MILLION)
5.15.2 EXPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS
TABLE 17 EXPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2018-2022 (USD MILLION)
5.16 INDUSTRY TRENDS
5.16.1 DETECTION OF HIV WITH LATERAL FLOW ASSAYS
TABLE 18 US: HIV PREVALENCE RATE, 2016-2021
5.16.2 INCREASING ADOPTION OF QUANTITATIVE LATERAL FLOW ASSAYS DUE TO AVAILABILITY OF LFA READERS
5.17 KEY STAKEHOLDERS AND BUYING CRITERIA
5.17.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 33 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
5.17.2 BUYING CRITERIA
FIGURE 34 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
5.18 MARKET: IMPACT OF INFLATION AND RECESSION
5.19 ARTIFICIAL INTELLIGENCE (AI) IN LATERAL FLOW ASSAY MARKET
TABLE 20 POTENTIAL APPLICATIONS OF AI IN LATERAL FLOW ASSAYS
5.2 UNMET NEEDS/END-USER EXPECTATIONS
TABLE 21 MARKET: UNMET NEEDS/END-USER EXPECTATIONS
5.21 INVESTMENT/VENTURE CAPITAL
FIGURE 35 MARKET: INVESTMENT/VENTURE CAPITAL SCENARIO, 2018-2022

6 LATERAL FLOW ASSAYS MARKET, BY PRODUCT (Page No. - 104)
6.1 INTRODUCTION
TABLE 22 LATERAL FLOW ASSAYS INDUSTRY, BY PRODUCT, 2021-2029 (USD MILLION)
6.2 KITS & REAGENTS
6.2.1 RISING DEMAND FOR POC TESTING TO DRIVE MARKET
TABLE 23 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
6.3 READERS
TABLE 24 LATERAL FLOW READERS OFFERED, BY COMPANY
TABLE 25 INDICATIVE LIST OF LATERAL FLOW ASSAY KITS & REAGENTS: WITH AND WITHOUT ANALYZERS
TABLE 26 LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 27 LATERAL FLOW READERS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
6.3.1 DIGITAL/HANDHELD READERS
6.3.1.1 Technological evolutions and accuracy to drive adoption
TABLE 28 DIGITAL/HANDHELD LATERAL FLOW READERS MARKET, BY COUNTRY, 2021-2029 (USD MILLION).
6.3.2 BENCHTOP READERS
6.3.2.1 Lower diagnosis cost per patient to drive adoption
TABLE 29 BENCHTOP LATERAL FLOW READERS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
6.3.3 INSIGHTS ON DISPOSABLE AND REUSABLE LATERAL FLOW ASSAY READERS
6.3.4 LATERAL FLOW READERS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE
TABLE 30 PRODUCT PORTFOLIO ANALYSIS OF LATERAL FLOW READERS FOR CLINICAL DIAGNOSTICS
FIGURE 36 PRODUCT PORTFOLIO ANALYSIS OF LATERAL FLOW READERS FOR CLINICAL DIAGNOSTICS (2022)

7 LATERAL FLOW ASSAYS MARKET, BY APPLICATION (Page No. - 115)
7.1 INTRODUCTION
TABLE 31 LATERAL FLOW ASSAYS INDUSTRY, BY APPLICATION, 2021-2029 (USD MILLION)
7.2 CLINICAL TESTING
TABLE 32 MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 33 MARKET FOR CLINICAL TESTING, BY COUNTRY, 2021-2029 (USD MILLION)
7.2.1 INFECTIOUS DISEASE TESTING
TABLE 34 MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
TABLE 35 MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2021-2029 (USD MILLION)
7.2.1.1 Mosquito-borne diseases
7.2.1.1.1 Increasing incidence of dengue to drive market
TABLE 36 MAJOR PRODUCTS: DENGUE TESTING
TABLE 37 MARKET FOR MOSQUITO-BORNE DISEASES, BY COUNTRY, 2021-2029 (USD MILLION)
7.2.1.2 COVID-19
7.2.1.2.1 Demand for testing to drive market for COVID-19 assays
FIGURE 37 NORTH MARKET SIZING FOR COVID-19: SCENARIO-BASED FORECASTING
TABLE 38 COVID-19 (ANTIGEN AND ANTIBODY) LATERAL FLOW ASSAY TESTS
TABLE 39 MARKET FOR COVID-19, BY COUNTRY, 2021-2029 (USD MILLION)
7.2.1.3 Influenza
7.2.1.3.1 Rising prevalence of influenza globally to boost market growth
TABLE 40 MARKET FOR INFLUENZA, BY COUNTRY, 2021-2029 (USD MILLION)
7.2.1.4 Sexually transmitted infections
TABLE 41 MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
TABLE 42 MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2021-2029 (USD MILLION)
7.2.1.4.1 HIV
TABLE 43 MARKET FOR HIV, BY COUNTRY, 2021-2029 (USD MILLION)
7.2.1.4.2 HPV
TABLE 44 MARKET FOR HPV, BY COUNTRY, 2021-2029 (USD MILLION)
7.2.1.4.3 Chlamydia
TABLE 45 MARKET FOR CHLAMYDIA, BY COUNTRY, 2021-2029
7.2.1.4.4 Gonorrhea
TABLE 46 MARKET FOR GONORRHEA, BY COUNTRY, 2021-2029 (USD MILLION)
7.2.1.4.5 Syphilis
TABLE 47 MARKET FOR SYPHILIS, BY COUNTRY, 2021-2029 (USD MILLION)
7.2.1.4.6 Other sexually transmitted infections
TABLE 48 MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2021-2029 (USD MILLION)
7.2.1.5 Hepatitis
7.2.1.5.1 Nucleic acid hybridization-based LFAs to show strong potential in hepatitis testing
TABLE 49 MARKET FOR HEPATITIS, BY COUNTRY, 2021-2029 (USD MILLION)
7.2.1.6 Tuberculosis
7.2.1.6.1 Rising prevalence and growing focus on early diagnosis and treatment to drive market
TABLE 50 MARKET FOR TUBERCULOSIS, BY COUNTRY, 2021-2029 (USD MILLION)
7.2.1.7 Other infectious diseases
TABLE 51 MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2021-2029 (USD MILLION)
7.2.2 CARDIAC MARKER TESTING
TABLE 52 MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 53 MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2021-2029 (USD MILLION)
7.2.2.1 Troponin I & T
7.2.2.1.1 Introduction of high-sensitivity troponin assays to drive market
TABLE 54 MARKET FOR TROPONIN I & T TESTING, BY COUNTRY, 2021-2029 (USD MILLION)
7.2.2.2 CK-MB
7.2.2.2.1 Growing applications of lateral flow tests in acute myocardial injuries to drive market
TABLE 55 MARKET FOR CK-MB TESTING, BY COUNTRY, 2021-2029 (USD MILLION)
7.2.2.3 BNP & NT-proBNP
7.2.2.3.1 Increasing demand for cardiac biomarker tests to detect heart stress and damage to drive growth
TABLE 56 MARKET FOR BNP & NT-PROBNP TESTING, BY COUNTRY, 2021-2029 (USD MILLION)
7.2.2.4 Myoglobin
7.2.2.4.1 Availability of new high-sensitivity cardiac troponin assays to restrict market growth
TABLE 57 MARKET FOR MYOGLOBIN TESTING, BY COUNTRY, 2021-2029 (USD MILLION)
7.2.2.5 D-Dimer
7.2.2.5.1 Rising incidence of CVDs to drive market for D-dimer tests
TABLE 58 MARKET FOR D-DIMER TESTING, BY COUNTRY, 2021-2029 (USD MILLION)
7.2.2.6 Other cardiac marker tests
TABLE 59 MARKET FOR OTHER CARDIAC MARKER TESTS, BY COUNTRY, 2021-2029 (USD MILLION)
7.2.3 PREGNANCY & FERTILITY TESTING
TABLE 60 MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 61 MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2021-2029 (USD MILLION)
7.2.3.1 Pregnancy testing
7.2.3.1.1 Pregnancy testing to hold larger market share but register slower growth
TABLE 62 MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2021-2029 (USD MILLION)
7.2.3.2 Fertility testing
7.2.3.2.1 Rising infertility rates to drive demand for POC fertility testing kits
TABLE 63 MARKET FOR FERTILITY TESTING, BY COUNTRY, 2021-2029 (USD MILLION)
7.2.4 CHOLESTEROL/LIPID TESTING
7.2.4.1 Lifestyle changes, rising obesity prevalence to drive market
TABLE 64 MARKET FOR CHOLESTEROL/LIPID TESTING, BY COUNTRY, 2021-2029 (USD MILLION)
7.2.5 DRUGS-OF-ABUSE TESTING
7.2.5.1 Technological advancements and rising focus on workplace drug testing to drive market
TABLE 65 MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2021-2029 (USD MILLION)
7.2.6 OTHER CLINICAL TESTS
TABLE 66 MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY, 2021-2029 (USD MILLION)
7.3 VETERINARY DIAGNOSTICS
7.3.1 INFECTIOUS DISEASE OUTBREAKS TO DRIVE MARKET
TABLE 67 MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2021-2029 (USD MILLION)
7.4 FOOD SAFETY & ENVIRONMENT TESTING
7.4.1 HIGH SENSITIVITY AND EASE OF USE TO BOOST DEMAND FOR ASSAYS
TABLE 68 MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING, BY COUNTRY, 2021-2029 (USD MILLION)
7.5 DRUG DEVELOPMENT & QUALITY TESTING
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO SUPPORT MARKET GROWTH
TABLE 69 MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY COUNTRY, 2021-2029 (USD MILLION)

8 LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE (Page No. - 165)
8.1 INTRODUCTION
TABLE 70 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
TABLE 71 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
8.2 SANDWICH ASSAYS
8.2.1 WIDE APPLICATIONS IN CLINICAL TESTING TO SUPPORT MARKET GROWTH
TABLE 72 LATERAL FLOW SANDWICH ASSAYS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
8.3 COMPETITIVE ASSAYS
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY COMPARED TO SANDWICH ASSAYS TO HAMPER GROWTH
TABLE 73 LATERAL FLOW COMPETITIVE ASSAYS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
8.4 MULTIPLEX DETECTION ASSAYS
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET
TABLE 74 LATERAL FLOW MULTIPLEX DETECTION ASSAYS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)

9 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE (Page No. - 172)
9.1 INTRODUCTION
TABLE 75 LATERAL FLOW ASSAYS INDUSTRY FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
9.2 BLOOD SAMPLES
9.2.1 INCREASING USE OF BLOOD SAMPLES FOR INFECTIOUS DISEASE TESTING TO DRIVE MARKET
TABLE 76 MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2021-2029 (USD MILLION)
9.3 URINE SAMPLES
9.3.1 GROWING USE OF URINE SAMPLES FOR PREGNANCY AND DRUGS-OF-ABUSE TESTING TO DRIVE MARKET
TABLE 77 MARKET FOR URINE SAMPLES, BY COUNTRY, 2021-2029 (USD MILLION)
9.4 SALIVA SAMPLES
9.4.1 EASY AND LOW-COST COLLECTION, TRANSPORT, AND ANALYSIS OF SALIVA SAMPLES TO SUPPORT ADOPTION
TABLE 78 MARKET FOR SALIVA SAMPLES, BY COUNTRY, 2021-2029 (USD MILLION)
9.5 OTHER SAMPLES
TABLE 79 MARKET FOR OTHER SAMPLES, BY COUNTRY, 2021-2029 (USD MILLION)

10 LATERAL FLOW ASSAYS MARKET, BY END USER (Page No. - 178)
10.1 INTRODUCTION
TABLE 80 LATERAL FLOW ASSAYS INDUSTRY, BY END USER, 2021-2029 (USD MILLION)
10.2 HOSPITALS & CLINICS
10.2.1 INCREASING USE OF POC TESTS TO DRIVE MARKET
TABLE 81 MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021-2029 (USD MILLION)
10.3 HOME CARE SETTINGS
10.3.1 GROWING ACCEPTANCE OF REMOTE MONITORING TO PROPEL MARKET
TABLE 82 MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2021-2029 (USD MILLION)
10.4 DIAGNOSTIC LABORATORIES
10.4.1 LABORATORY TESTING LARGELY PREFERRED OVER PROFESSIONAL SETTINGS FOR URINE AND BLOOD TESTING
TABLE 83 MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021-2029 (USD MILLION)
10.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.5.1 INCREASING FOCUS ON PRODUCT SAFETY TO DRIVE ADOPTION OF LATERAL FLOW ASSAYS
TABLE 84 MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2029 (USD MILLION)
10.6 OTHER END USERS
TABLE 85 MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2029 (USD MILLION)

11 LATERAL FLOW ASSAYS MARKET, BY REGION (Page No. - 186)
11.1 INTRODUCTION
FIGURE 38 CHINA TO WITNESS HIGHEST GROWTH IN FORECAST PERIOD
TABLE 86 LATERAL FLOW ASSAYS INDUSTRY, BY REGION, 2021-2029 (USD MILLION)
11.2 NORTH AMERICA
TABLE 87 NORTH AMERICA: MACROECONOMIC INDICATORS
FIGURE 39 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET SNAPSHOT
TABLE 88 NORTH AMERICA: MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 89 NORTH AMERICA: MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
TABLE 90 NORTH AMERICA: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 91 NORTH AMERICA: MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 92 NORTH AMERICA: MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 93 NORTH AMERICA: MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
TABLE 94 NORTH AMERICA: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
TABLE 95 NORTH AMERICA: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 96 NORTH AMERICA: MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 97 NORTH AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
TABLE 98 NORTH AMERICA: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
TABLE 99 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)
11.2.1 NORTH AMERICA: RECESSION IMPACT
11.2.2 US
11.2.2.1 US to hold largest market share of global market, by country
TABLE 100 US: MACROECONOMIC INDICATORS
TABLE 101 US: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
TABLE 102 US: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 103 US: MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 104 US: MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 105 US: MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
TABLE 106 US: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
TABLE 107 US: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 108 US: MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 109 US: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
TABLE 110 US: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
TABLE 111 US: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029USD MILLION)
11.2.3 CANADA
11.2.3.1 Availability of research funding and implementation of favorable government initiatives to drive market
TABLE 112 CANADA: MACROECONOMIC INDICATORS
TABLE 113 CANADA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
TABLE 114 CANADA: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 115 CANADA: MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 116 CANADA: MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 117 CANADA: MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
TABLE 118 CANADA: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
TABLE 119 CANADA: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 120 CANADA: MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 121 CANADA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
TABLE 122 CANADA: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
TABLE 123 CANADA: MARKET, BY END USER, 2021-2029USD MILLION)
11.3 EUROPE
11.3.1 EUROPE: RECESSION IMPACT
TABLE 124 EUROPE: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 125 EUROPE: MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
TABLE 126 EUROPE: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 127 EUROPE: MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 128 EUROPE: MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 129 EUROPE: MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
TABLE 130 EUROPE: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
TABLE 131 EUROPE: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 132 EUROPE: MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 133 EUROPE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
TABLE 134 EUROPE: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
TABLE 135 EUROPE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)
11.3.2 GERMANY
11.3.2.1 Growing number of POC diagnostics centers to drive demand
TABLE 136 GERMANY: MACROECONOMIC INDICATORS
TABLE 137 GERMANY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
TABLE 138 GERMANY: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 139 GERMANY: MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 140 GERMANY: MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 141 GERMANY: MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
TABLE 142 GERMANY: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
TABLE 143 GERMANY: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 144 GERMANY: MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 145 GERMANY: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
TABLE 146 GERMANY: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
TABLE 147 GERMANY: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)
11.3.3 FRANCE
11.3.3.1 High prevalence of age-related chronic diseases and infectious diseases to drive market
TABLE 148 FRANCE: MACROECONOMIC INDICATORS
TABLE 149 FRANCE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
TABLE 150 FRANCE: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 151 FRANCE: MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 152 FRANCE: MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 153 FRANCE: MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
TABLE 154 FRANCE: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
TABLE 155 FRANCE: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 156 FRANCE: MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 157 FRANCE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
TABLE 158 FRANCE: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
TABLE 159 FRANCE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)
11.3.4 UK
11.3.4.1 Rising prevalence of obesity to propel market
TABLE 160 UK: MACROECONOMIC INDICATORS
TABLE 161 UK: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
TABLE 162 UK: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 163 UK: MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 164 UK: MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 165 UK: MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
TABLE 166 UK: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
TABLE 167 UK: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 168 UK: MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 169 UK: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
TABLE 170 UK: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
TABLE 171 UK: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)
11.3.5 ITALY
11.3.5.1 Growing initiatives toward decentralization of medical services to support market growth
TABLE 172 ITALY: MACROECONOMIC INDICATORS
TABLE 173 ITALY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
TABLE 174 ITALY: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 175 ITALY: MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 176 ITALY: MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 177 ITALY: MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
TABLE 178 ITALY: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
TABLE 179 ITALY: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 180 ITALY: MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 181 ITALY: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
TABLE 182 ITALY: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
TABLE 183 ITALY: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)
11.3.6 SPAIN
11.3.6.1 Increasing focus of international organizations and domestic players on developing POC products to aid market growth
TABLE 184 SPAIN: MACROECONOMIC INDICATORS
TABLE 185 SPAIN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
TABLE 186 SPAIN: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 187 SPAIN: MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 188 SPAIN: MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 189 SPAIN: MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
TABLE 190 SPAIN: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
TABLE 191 SPAIN: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 192 SPAIN: MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 193 SPAIN: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
TABLE 194 SPAIN: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
TABLE 195 SPAIN: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)
11.3.7 REST OF EUROPE
TABLE 196 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
TABLE 197 REST OF EUROPE: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 198 REST OF EUROPE: MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 199 REST OF EUROPE: MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 200 REST OF EUROPE: MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
TABLE 201 REST OF EUROPE: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
TABLE 202 REST OF EUROPE: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 203 REST OF EUROPE: MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 204 REST OF EUROPE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
TABLE 205 REST OF EUROPE: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
TABLE 206 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)
11.4 ASIA PACIFIC
11.4.1 ASIA PACIFIC: RECESSION IMPACT
FIGURE 40 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET SNAPSHOT
TABLE 207 ASIA PACIFIC: MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 208 ASIA PACIFIC: MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
TABLE 209 ASIA PACIFIC: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 210 ASIA PACIFIC: MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 211 ASIA PACIFIC: MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 212 ASIA PACIFIC: MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
TABLE 213 ASIA PACIFIC: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
TABLE 214 ASIA PACIFIC: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 215 ASIA PACIFIC: MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 216 ASIA PACIFIC: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
TABLE 217 ASIA PACIFIC: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
TABLE 218 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)
11.4.2 CHINA
11.4.2.1 Growing adoption of lateral flow assays in veterinary diagnostics and drug development to drive market
TABLE 219 CHINA: MACROECONOMIC INDICATORS
TABLE 220 CHINA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
TABLE 221 CHINA: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 222 CHINA: MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 223 CHINA: MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 224 CHINA: MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
TABLE 225 CHINA: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
TABLE 226 CHINA: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 227 CHINA: MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 228 CHINA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
TABLE 229 CHINA: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
TABLE 230 CHINA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)
11.4.3 JAPAN
11.4.3.1 Increasing prevalence of age-related illnesses to drive market
TABLE 231 JAPAN: MACROECONOMIC INDICATORS
TABLE 232 JAPAN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
TABLE 233 JAPAN: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 234 JAPAN: MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 235 JAPAN: MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 236 JAPAN: MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
TABLE 237 JAPAN: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
TABLE 238 JAPAN: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 239 JAPAN: MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 240 JAPAN: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
TABLE 241 JAPAN: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
TABLE 242 JAPAN: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)
11.4.4 INDIA
11.4.4.1 Growing healthcare concerns and rising income levels to propel market growth
TABLE 243 INDIA: MACROECONOMIC INDICATORS
TABLE 244 INDIA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
TABLE 245 INDIA: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 246 INDIA: MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 247 INDIA: MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 248 INDIA: MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
TABLE 249 INDIA: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
TABLE 250 INDIA: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 251 INDIA: MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 252 INDIA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
TABLE 253 INDIA: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
TABLE 254 INDIA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)
11.4.5 AUSTRALIA
11.4.5.1 Increasing prevalence of infectious diseases, especially influenza, to drive market
TABLE 255 AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
TABLE 256 AUSTRALIA: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 257 AUSTRALIA: MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 258 AUSTRALIA: MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 259 AUSTRALIA: MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
TABLE 260 AUSTRALIA: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
TABLE 261 AUSTRALIA: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 262 AUSTRALIA: MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 263 AUSTRALIA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
TABLE 264 AUSTRALIA: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
TABLE 265 AUSTRALIA: MARKET, BY END USER, 2021-2029 (USD MILLION)
11.4.6 SOUTH KOREA
TABLE 266 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
TABLE 267 SOUTH KOREA: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 268 SOUTH KOREA: MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 269 SOUTH KOREA: MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 270 SOUTH KOREA: MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
TABLE 271 SOUTH KOREA: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
TABLE 272 SOUTH KOREA: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 273 SOUTH KOREA: MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 274 SOUTH KOREA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
TABLE 275 SOUTH KOREA: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
TABLE 276 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)
11.4.7 REST OF ASIA PACIFIC
TABLE 277 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
TABLE 278 REST OF ASIA PACIFIC: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 279 REST OF ASIA PACIFIC: MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 280 REST OF ASIA PACIFIC: MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 281 REST OF ASIA PACIFIC: MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
TABLE 282 REST OF ASIA PACIFIC: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
TABLE 283 REST OF ASIA PACIFIC: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 284 REST OF ASIA PACIFIC: MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 285 REST OF ASIA PACIFIC: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
TABLE 286 REST OF ASIA PACIFIC: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
TABLE 287 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)
11.5 LATIN AMERICA
11.5.1 LATIN AMERICA: RECESSION IMPACT
TABLE 288 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 289 LATIN AMERICA: MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
TABLE 290 LATIN AMERICA: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 291 LATIN AMERICA: MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 292 LATIN AMERICA: MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 293 LATIN AMERICA: MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
TABLE 294 LATIN AMERICA: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
TABLE 295 LATIN AMERICA: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 296 LATIN AMERICA: MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 297 LATIN AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
TABLE 298 LATIN AMERICA: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
TABLE 299 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)
11.5.2 BRAZIL
11.5.2.1 High private healthcare expenditure and rising geriatric population to drive market
TABLE 300 BRAZIL: MACROECONOMIC INDICATORS
TABLE 301 BRAZIL: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
TABLE 302 BRAZIL: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 303 BRAZIL: MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 304 BRAZIL: MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 305 BRAZIL: MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
TABLE 306 BRAZIL: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
TABLE 307 BRAZIL: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 308 BRAZIL: MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 309 BRAZIL: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
TABLE 310 BRAZIL: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
TABLE 311 BRAZIL: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)
11.5.3 MEXICO
11.5.3.1 High prevalence of obesity and related chronic diseases to propel market
TABLE 312 MEXICO: MACROECONOMIC INDICATORS
TABLE 313 MEXICO: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
TABLE 314 MEXICO: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 315 MEXICO: MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 316 MEXICO: MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 317 MEXICO: MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
TABLE 318 MEXICO: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
TABLE 319 MEXICO: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 320 MEXICO: MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 321 MEXICO: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
TABLE 322 MEXICO: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
TABLE 323 MEXICO: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)
11.5.4 ARGENTINA
11.5.4.1 Availability of health insurance to favor market growth
TABLE 324 ARGENTINA: MACROECONOMIC INDICATORS
TABLE 325 ARGENTINA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
TABLE 326 ARGENTINA: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 327 ARGENTINA: MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 328 ARGENTINA: MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 329 ARGENTINA: MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
TABLE 330 ARGENTINA: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
TABLE 331 ARGENTINA: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 332 ARGENTINA: MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 333 ARGENTINA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
TABLE 334 ARGENTINA: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
TABLE 335 ARGENTINA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)
11.5.5 REST OF LATIN AMERICA
TABLE 336 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
TABLE 337 REST OF LATIN AMERICA: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 338 REST OF LATIN AMERICA: MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 339 REST OF LATIN AMERICA: MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 340 REST OF LATIN AMERICA: MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
TABLE 341 REST OF LATIN AMERICA: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
TABLE 342 REST OF LATIN AMERICA: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 343 REST OF LATIN AMERICA: MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 344 REST OF LATIN AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
TABLE 345 REST OF LATIN AMERICA: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
TABLE 346 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)
11.6 MIDDLE EAST & AFRICA
11.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TO DRIVE MARKET
11.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
TABLE 347 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
TABLE 348 MIDDLE EAST & AFRICA: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 349 MIDDLE EAST & AFRICA: MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 350 MIDDLE EAST & AFRICA: MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 351 MIDDLE EAST & AFRICA: MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
TABLE 352 MIDDLE EAST & AFRICA: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
TABLE 353 MIDDLE EAST & AFRICA: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 354 MIDDLE EAST & AFRICA: MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 355 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
TABLE 356 MIDDLE EAST & AFRICA: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
TABLE 357 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)
11.6.3 GCC COUNTRIES
11.6.3.1 GCC countries: Recession impact
TABLE 358 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
TABLE 359 GCC COUNTRIES: LATERAL FLOW READERS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 360 GCC COUNTRIES: MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
TABLE 361 GCC COUNTRIES: MARKET FOR CLINICAL TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 362 GCC COUNTRIES: MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021-2029 (USD MILLION)
TABLE 363 GCC COUNTRIES: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021-2029 (USD MILLION)
TABLE 364 GCC COUNTRIES: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 365 GCC COUNTRIES: MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021-2029 (USD MILLION)
TABLE 366 GCC COUNTRIES: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021-2029 (USD MILLION)
TABLE 367 GCC COUNTRIES: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021-2029 (USD MILLION)
TABLE 368 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021-2029 (USD MILLION)

12 COMPETITIVE LANDSCAPE (Page No. - 321)
12.1 OVERVIEW
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
TABLE 369 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN LATERAL FLOW ASSAYS MARKET
12.3 REVENUE SHARE ANALYSIS
FIGURE 41 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN PAST FIVE YEARS
12.4 MARKET SHARE ANALYSIS
FIGURE 42 LATERAL FLOW ASSAYS INDUSTRY SHARE ANALYSIS, BY KEY PLAYER (2022)
TABLE 370 LATERAL FLOW ASSAYS INDUSTRY: DEGREE OF COMPETITION
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS
12.5.1 STARS
12.5.2 PERVASIVE PLAYERS
12.5.3 EMERGING LEADERS
12.5.4 PARTICIPANTS
FIGURE 43 LATERAL FLOW ASSAYS INDUSTRY: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2022
12.5.5 COMPANY FOOTPRINT
FIGURE 44 COMPANY FOOTPRINT (25 COMPANIES)
TABLE 371 PRODUCT FOOTPRINT (25 COMPANIES)
TABLE 372 TECHNIQUE FOOTPRINT (25 COMPANIES)
TABLE 373 APPLICATION FOOTPRINT (25 COMPANIES)
TABLE 374 SAMPLE TYPE FOOTPRINT (25 COMPANIES)
TABLE 375 END-USER FOOTPRINT (25 COMPANIES)
TABLE 376 REGIONAL FOOTPRINT (25 COMPANIES)
12.6 COMPANY EVALUATION MATRIX: SMES & STARTUPS
12.6.1 PROGRESSIVE COMPANIES
12.6.2 DYNAMIC COMPANIES
12.6.3 STARTING BLOCKS
12.6.4 RESPONSIVE COMPANIES
FIGURE 45 LATERAL FLOW ASSAYS INDUSTRY: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2022
12.6.5 COMPETITIVE BENCHMARKING
TABLE 377 LATERAL FLOW ASSAY MARKET: DETAILED LIST OF KEY STARTUP/SMES
TABLE 378 LATERAL FLOW ASSAY MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUP/SMES
12.7 COMPETITIVE SCENARIO
12.7.1 PRODUCT LAUNCHES & APPROVALS
TABLE 379 LATERAL FLOW ASSAYS INDUSTRY: PRODUCT LAUNCHES & APPROVALS, JANUARY 2020-DECEMBER 2023
12.7.2 DEALS
TABLE 380 LATERAL FLOW ASSAYS INDUSTRY: DEALS, JANUARY 2020-DECEMBER 2023
12.7.3 EXPANSIONS
TABLE 381 LATERAL FLOW ASSAYS INDUSTRY: EXPANSIONS (JANUARY 2020-DECEMBER 2023)
12.7.4 OTHER DEVELOPMENTS
TABLE 382 LATERAL FLOW ASSAYS INDUSTRY: OTHER DEVELOPMENTS, JANUARY 2020-DECEMBER 2023
12.8 R&D ASSESSMENT OF KEY PLAYERS
FIGURE 46 R&D EXPENDITURE: MAJOR PLAYERS IN LATERAL FLOW ASSAYS INDUSTRY, 2021 VS. 2022
12.9 INVESTMENT LANDSCAPE
FIGURE 47 LATERAL FLOW ASSAY MARKET FUNDING SOARED IN 2022
FIGURE 48 MOST VALUED LATERAL FLOW ASSAY FIRMS IN 2022 (USD BILLION)
12.10 VALUATION AND FINANCIAL MATRICES
FIGURE 49 LATERAL FLOW ASSAYS INDUSTRY: VALUATION AND FINANCIAL MATRICES

13 COMPANY PROFILES (Page No. - 341)
13.1 KEY PLAYERS
(Business overview, Products offered, Recent developments, Deals, MnM view, Key Strengths/Right to win, Strategic choices made, and Weaknesses and Competitive threats)*
13.1.1 ABBOTT LABORATORIES
TABLE 383 ABBOTT LABORATORIES: COMPANY OVERVIEW
FIGURE 50 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022)
TABLE 384 ABBOTT LABORATORIES: PRODUCTS OFFERED
TABLE 385 ABBOTT LABORATORIES: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020-DECEMBER 2023)
TABLE 386 ABBOTT LABORATORIES: DEALS (JANUARY 2020-DECEMBER 2023)
13.1.2 F. HOFFMANN-LA ROCHE LTD.
TABLE 387 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
FIGURE 51 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022)
TABLE 388 F. HOFFMAN-LA ROCHE: PRODUCTS OFFERED
TABLE 389 F. HOFFMAN-LA ROCHE: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020-DECEMBER 2023)
TABLE 390 F. HOFFMAN-LA ROCHE: DEALS (JANUARY 2020-DECEMBER 2023)
TABLE 391 F. HOFFMAN-LA ROCHE: EXPANSIONS (JANUARY 2020-DECEMBER 2023)
13.1.3 QUIDELORTHO CORPORATION
TABLE 392 QUIDELORTHO CORPORATION: COMPANY OVERVIEW
FIGURE 52 QUIDELORTHO CORPORATION: COMPANY SNAPSHOT (2022)
TABLE 393 QUIDELORTHO CORPORATION: PRODUCTS OFFERED
TABLE 394 QUIDELORTHO CORPORATION: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020-DECEMBER 2023)
TABLE 395 QUIDELORTHO CORPORATION: DEALS (JANUARY 2020-DECEMBER 2023)
13.1.4 DANAHER CORPORATION
TABLE 396 DANAHER CORPORATION: COMPANY OVERVIEW
FIGURE 53 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
TABLE 397 DANAHER CORPORATION: PRODUCTS OFFERED
TABLE 398 DANAHER CORPORATION: DEALS (JANUARY 2020-DECEMBER 2023)
13.1.5 SIEMENS AG
TABLE 399 SIEMENS AG: COMPANY OVERVIEW
FIGURE 54 SIEMENS AG: COMPANY SNAPSHOT (2022)
TABLE 400 SIEMENS AG: PRODUCTS OFFERED
TABLE 401 SIEMENS AG: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020-DECEMBER 2023)
13.1.6 BECTON, DICKINSON AND COMPANY
TABLE 402 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
FIGURE 55 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
TABLE 403 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
TABLE 404 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020-DECEMBER 2023)
TABLE 405 BECTON, DICKINSON AND COMPANY: DEALS (JANUARY 2020-DECEMBER 2023)
TABLE 406 BECTON, DICKINSON AND COMPANY: OTHER DEVELOPMENTS (JANUARY 2020-DECEMBER 2023)
13.1.7 BIOMÉRIEUX SA
TABLE 407 BIOMÉRIEUX SA: COMPANY OVERVIEW
FIGURE 56 BIOMÉRIEUX SA: COMPANY SNAPSHOT (2022)
TABLE 408 BIOMÉRIEUX SA: PRODUCTS OFFERED
TABLE 409 BIOMÉRIEUX SA: DEALS (JANUARY 2020-DECEMBER 2023)
13.1.8 THERMO FISHER SCIENTIFIC INC.
TABLE 410 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
FIGURE 57 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
TABLE 411 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
TABLE 412 THERMO FISHER SCIENTIFIC INC.: PRODUCT APPROVALS (JANUARY 2020-DECEMBER 2023)
TABLE 413 THERMO FISHER SCIENTIFIC INC.: DEALS (JANUARY 2020-DECEMBER 2023)
13.1.9 PERKINELMER INC.
TABLE 414 PERKINELMER INC.: COMPANY OVERVIEW
FIGURE 58 PERKINELMER INC.: COMPANY SNAPSHOT (2022)
TABLE 415 PERKINELMER INC.: PRODUCTS OFFERED
TABLE 416 PERKINELMER INC.: PRODUCT LAUNCHES (JANUARY 2020-DECEMBER 2023)
TABLE 417 PERKINELMER INC.: DEALS (JANUARY 2020-DECEMBER 2023)
13.1.10 QIAGEN N.V.
TABLE 418 QIAGEN N.V.: COMPANY OVERVIEW
FIGURE 59 QIAGEN N.V.: COMPANY SNAPSHOT (2022)
TABLE 419 QIAGEN N.V.: PRODUCTS OFFERED
TABLE 420 QIAGEN N.V.: DEALS (JANUARY 2020-DECEMBER 2023)
13.2 OTHER PLAYERS
13.2.1 MERCK KGAA
13.2.2 HOLOGIC, INC.
13.2.3 ABCAM PLC
13.2.4 SURMODICS INC.
13.2.5 CHEMBIO DIAGNOSTICS, INC. (BIOSYNEX)
13.2.6 ORASURE TECHNOLOGIES
13.2.7 DCN DIAGNOSTICS
13.2.8 POLYSCIENCES INC.
13.2.9 ABINGDON HEALTH
13.2.10 ORANOXIS INC.
13.2.11 AESKU.GROUP GMBH
13.2.12 BIO GROUP MEDICAL SYSTEM S.R.L
13.2.13 PHARMACT GMBH
13.2.14 DIESSE DIAGNOSTICA SENESE S.P.A.
13.2.15 XIAMEN BIOTIME BIOTECHNOLOGY CO., LTD.
*Details on Business overview, Products offered, Recent developments, Product launches, Deals, MnM view, Key Strengths/Right to win, Strategic choices made, and Weaknesses and Competitive threats might not be captured in case of unlisted companies.

14 APPENDIX (Page No. - 391)
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS